null

Tinurilimab Biosimilar (Anti-CEACAM6) Antibody (HDBS0088)

SKU:
HDBS0088
Product Type:
Biosimilar Antibody
Antibody Type:
Monoclonal Antibody
Protein:
CEACAM6
Reactivity:
Human
Host Species:
Human
Isotype:
IgG2
€399
Frequently bought together:

Description

system_update_altDatasheet

Tinurilimab (Anti-CEACAM6) Biosimilar Antibody (HDBS0088)

The Tinurilimab Biosimilar Anti-CEACAM6 Antibody is a revolutionary product designed for research involving CEACAM6, a cell surface molecule that plays a crucial role in multiple biological processes. This biosimilar antibody, produced using advanced technology, is highly specific and reactive with human samples, making it an ideal tool for research in oncology, immunology, and beyond.The antibody binds to the CEACAM6 protein, enabling precise detection and analysis in various cell types. Its high specificity and sensitivity make it a valuable tool for studying the role of CEACAM6 in cancer progression, immune regulation, and other physiological processes. Additionally, the antibody is validated for use in various applications, including Western blot, immunohistochemistry, and flow cytometry, providing researchers with versatile options for their studies.

CEACAM6, also known as carcinoembryonic antigen-related cell adhesion molecule 6, is a promising target for therapeutic development in cancer and inflammatory diseases. Its overexpression has been linked to tumor progression, metastasis, and immune evasion, making it a potential biomarker for cancer diagnosis and prognosis. Furthermore, understanding the function of CEACAM6 can provide valuable insights into the development of targeted therapies for cancer and immunological disorders.In conclusion, the Tinurilimab Biosimilar Anti-CEACAM6 Antibody is a valuable research tool for scientists studying CEACAM6 and its role in various biological processes. With its high specificity